CN Patent

CN103228619A — 钙传感受体活性化合物

Assigned to Leo Pharma AS · Expires 2013-07-31 · 13y expired

What this patent protects

通式(I)化合物、其作为钙受体活性化合物用于预防、治疗或改善与CaSR活性失调相关的生理学紊乱或疾病如甲状旁腺功能亢进的用途、包含所述化合物的药物组合物以及用所述化合物治疗疾病的方法。

USPTO Abstract

通式(I)化合物、其作为钙受体活性化合物用于预防、治疗或改善与CaSR活性失调相关的生理学紊乱或疾病如甲状旁腺功能亢进的用途、包含所述化合物的药物组合物以及用所述化合物治疗疾病的方法。

Drugs covered by this patent

cinacalcet-hydrochloride (CINACALCET HYDROCHLORIDE)

Patent Metadata

Patent number: CN103228619A
Jurisdiction: CN
Classification: —
Expires: 2013-07-31
Drug substance claim: No
Drug product claim: No
Assignee: Leo Pharma AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.